Company Filing History:
2 out of 5,089 
2 out of 58 
1 out of 11 Years Active: 2011-2012
Title: The Innovations of Jean Michel Vierfond
Introduction
Jean Michel Vierfond is a notable inventor based in Maisons Alfort, France. He has made significant contributions to the field of biotechnology, particularly in the development of methods and kits for screening molecules with anti-prion activity. With a total of 2 patents, his work has implications for treating neurodegenerative diseases and conditions related to smooth muscle cell constriction.
Latest Patents
One of his latest patents focuses on "Screening molecules with anti-prion activity: kits, methods and screened molecules." This invention involves the creation of kits designed to screen for molecules that exhibit anti-prion activity. The kits include a [PSI+], phenotype yeast, an antibiogram, and an agent for purifying prions at sub-efficient doses. The yeast used in this screening contains the adel-14 allele of the ADE1 gene and an inactivated ERG6 gene. The methods developed through this invention aim to isolate a family of molecules with anti-prion activity, which can be utilized in producing medicines for treating neurodegenerative diseases that involve protein aggregates.
Another significant patent by Vierfond is related to "The use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction." This invention addresses the treatment of conditions such as hypertension and asthma, showcasing the versatility of his research in addressing critical health issues.
Career Highlights
Throughout his career, Jean Michel Vierfond has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Poitiers. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.
Collaborations
He has collaborated with notable colleagues, including Yvette Mettey and Marc Blondel, further enhancing the impact of his research and inventions.
Conclusion
Jean Michel Vierfond's contributions to the field of biotechnology through his innovative patents demonstrate his commitment to advancing medical science. His work in screening molecules for anti-prion activity and developing treatments for smooth muscle cell constriction diseases highlights the importance of innovation in addressing complex health challenges.